Tecsys (TSE:TCS) Posts Earnings Results

Tecsys (TSE:TCS) released its quarterly earnings results on Thursday. The company reported C$0.21 EPS for the quarter, FiscalAI reports. Tecsys had a return on equity of 9.76% and a net margin of 3.24%.The company had revenue of C$50.05 million during the quarter.

Here are the key takeaways from Tecsys’ conference call:

• Record fiscal 2026 results: Tecsys reported record revenue and adjusted EBITDA, with adjusted EBITDA rising 50% to CAD 20 million from CAD 13 million. Management said expanding SaaS revenue and margins are driving an inflection point in profitability.
• SaaS remains the primary growth engine: SaaS revenue grew 20% in fiscal 2026 and now represents more than 40% of total revenue, while SaaS margins approached 70% and are targeted to reach 80% over time.
• Healthcare opportunity and AI momentum: Management highlighted a CAD 1.6 billion estimated recurring-revenue opportunity across major U.S. health systems, CAD 153 million of expansion potential within existing accounts, and positive early uptake of the TecsysIQ AI platform.
• Strong liquidity and shareholder returns: Tecsys ended the year with CAD 31 million in cash, cash equivalents and short-term investments, while returning capital through CAD 13 million of share repurchases and CAD 5 million of dividends.
• Restructuring reflects legacy-product pressure: The company restructured during the fourth quarter to address declining customer spending on certain legacy products and redirect investment toward future opportunities, resulting in some workforce reductions.

Tecsys Price Performance

Shares of TCS stock opened at C$30.42 on Friday. Tecsys has a 52-week low of C$22.51 and a 52-week high of C$38.00. The company has a debt-to-equity ratio of 8.33, a quick ratio of 1.40 and a current ratio of 1.12. The firm has a market capitalization of C$438.57 million, a P/E ratio of 112.67 and a beta of 0.84. The stock has a 50 day moving average price of C$32.00 and a 200 day moving average price of C$32.19.

Insider Transactions at Tecsys

In other Tecsys news, Director David Brereton sold 1,700 shares of the company’s stock in a transaction on Friday, July 17th. The stock was sold at an average price of C$33.00, for a total value of C$56,100.00. Following the transaction, the director owned 714,572 shares of the company’s stock, valued at C$23,580,876. This represents a 0.24% decrease in their position. In the last three months, insiders sold 4,200 shares of company stock worth $133,322. 17.05% of the stock is owned by insiders.

Wall Street Analyst Weigh In

TCS has been the subject of several analyst reports. Canaccord Genuity Group raised Tecsys to a “strong-buy” rating in a research note on Thursday, August 6th. National Bank Financial upgraded Tecsys from a “sector perform” rating to an “outperform” rating and increased their price target for the company from C$40.00 to C$46.00 in a report on Wednesday, May 27th. TD Securities upgraded Tecsys to a “strong-buy” rating in a research report on Thursday, July 9th. Finally, TD set a C$39.00 price objective on shares of Tecsys and gave the stock a “buy” rating in a research note on Wednesday, July 8th. Two equities research analysts have rated the stock with a Strong Buy rating, three have given a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, Tecsys currently has an average rating of “Buy” and a consensus price target of C$38.70.

About Tecsys

Tecsys is trusted by mission-critical organizations in healthcare and distribution to build resilient, efficient and secure supply chains. A global provider of cloud-based, AI-driven software with deep domain expertise, Tecsys delivers real-time operational visibility and execution across critical workflows when performance and reliability matter most. Tecsys is publicly traded on the Toronto Stock Exchange (TCS). For more information, visit www.tecsys.com.